º£½ÇÉçÇø

Tom Hobman is a Professor and cell biologist/virologist who has made pivotal discoveries in our understanding of virus-host interactions and global regulation of gene expression. The current focus of his laboratory is the identification of host cell factors that can be targeted to mitigate infection of endemic and emerging viruses. Currently, he is working with a US pharmaceutical company to test and develop novel therapies for SARS-CoV-2 and other pathogenic RNA viruses.